+
Site Tour

Webinar 2022: Management of aortic and mitral valve disease

Torsten Doenst et al. Focus on the management of aortic and mitral valve disease with future treatment in mind. Including quality of life, preserving the long-treatment path, and the role of porcine tissue valves during a recorded webinar.

Related Videos

TAVI Summit - Cardiac imaging

Anatomical overview of the AV Valves

TAVI Summit - TAVR in bicuspid

Review the Trends | Tricuspid focus

Navitor™: Voice of the Experts Nicolas Dumonteil

M-TEER: patient selection and current evidence

TAVI Summit - Cardiac imaging and morphology

TAVI Summit - What is coming next

TRENDING TOPICS

TAVI Webinar 1- Key learnings for advanced TAVI

TAVI Webinar 1- when the present unlocks the future:key learnings for advances TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

Data Summary PFO closure in patients > 60 Years

EXPAND Study: Data overview

Epic Mitral – 10-Year Clinical Outcomes

PCR LV 2021: Navitor™ Live-in-a-box

CONNEXT


LIVE
RELATED EVENTS

AV Valves Summit 2024 | Closing of Day 2

TAVI Summit 2023: Aortic stenosis

TAVI Summit - TAVR in bicuspid

TAVI Summit - Drive TAVI to the next level

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline